RIPK2 Promotes Colorectal Cancer Metastasis by Protecting YAP Degradation from ITCH-Mediated Ubiquitination

Researchers identified receptor-interacting protein kinase 2 (RIPK2) as an independent risk factor for poor colorectal cancer prognosis.